News & Analysis on Clinical Trial Services & Contract Research And Development
Pharmaceutical companies in the developed world have already shifted substantial manufacturing and clinical trial work to emerging economies such as China and India, but a new study suggest they are increasingly counting on these countries for...
3M Drug Delivery Systems believes it has made an advance in the administration of high potency therapeutics through the skin using its solid microstructured transdermal system (sMTS).
Acquisitive Indian contract research organisation Veeda has added another company to its portfolio, buying International Oncology Network (ION) of the US.
Ranbaxy has claimed that a pharmaceutical company is making a concerted effort to depress the company's share price by initiating the accusations that the generics manufacturer falsified data to achieve compliance.
A new excipient could help drugmakers improve the delivery profiles of active pharmaceutical ingredients (API), according to US developer Eastman Chemical.